Infantile Periocular Haemangioma: Optimising the Therapeutic Response View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-06

AUTHORS

Robert H. Taylor

ABSTRACT

Oral propranolol is now established as the first-line treatment for infantile haemangiomas, and used in up to 20 % of all cases. Propranolol use in infants is most commonly instigated in a controlled environment to monitor for potential serious adverse events such as hypoglycaemia and hypotension. Two test doses are recommended, the first one of 300 μg/kg followed by 2-hourly monitoring. On the subsequent day, a further dose of 650 μg/kg is administered with the same monitoring. A dose of 2 mg/kg divided into three is started from the next day. Parents/carers need to be warned of common adverse effects, of which disturbed sleep is the commonest. Treatment is recommended for up to a year to avoid rebound growth and the need to restart the treatment. More... »

PAGES

157-160

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40272-016-0172-6

DOI

http://dx.doi.org/10.1007/s40272-016-0172-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034087761

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27043724


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemangioma, Capillary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propranolol", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "York Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417375.3", 
          "name": [
            "Eye Department, York Hospital, Wigginton Road, YO31 8HE, York, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taylor", 
        "givenName": "Robert H.", 
        "id": "sg:person.01366364604.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366364604.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/bjophthalmol-2011-300047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000004025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/adc.2010.208884", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002012463"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjd.12804", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003194294"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjd.14233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010054941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/archdischild-2014-306514", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012684038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjd.12217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016485182"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1404710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017117120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc0708819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019302191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2011.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025833378", 
          "https://doi.org/10.1038/eye.2011.233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(14)78109-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026485403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.2012-1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027114703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjd.12189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028491029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1440-1754.2012.02521.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031512903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2012.06.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031951898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2010.07.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034890388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjd.12432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035738030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0974-2077.129975", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036766525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archophthalmol.2011.40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041058827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1985.tb02686.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041372361"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2014.237", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043249771", 
          "https://doi.org/10.1038/eye.2014.237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpeds.2006.12.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046282100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/pde.12239", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049929192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.2010-0029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067828291"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-06", 
    "datePublishedReg": "2016-06-01", 
    "description": "Oral propranolol is now established as the first-line treatment for infantile haemangiomas, and used in up to 20\u00a0% of all cases. Propranolol use in infants is most commonly instigated in a controlled environment to monitor for potential serious adverse events such as hypoglycaemia and hypotension. Two test doses are recommended, the first one of 300\u00a0\u03bcg/kg followed by 2-hourly monitoring. On the subsequent day, a further dose of 650\u00a0\u03bcg/kg is administered with the same monitoring. A dose of 2\u00a0mg/kg divided into three is started from the next day. Parents/carers need to be warned of common adverse effects, of which disturbed sleep is the commonest. Treatment is recommended for up to a year to avoid rebound growth and the need to restart the treatment. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40272-016-0172-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1020815", 
        "issn": [
          "1174-5878", 
          "1179-2019"
        ], 
        "name": "Pediatric Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "Infantile Periocular Haemangioma: Optimising the Therapeutic Response", 
    "pagination": "157-160", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a2627121343bcf6f9b41313f83a65230af365992e9069671d0f95ee37b115eff"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27043724"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100883685"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40272-016-0172-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034087761"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40272-016-0172-6", 
      "https://app.dimensions.ai/details/publication/pub.1034087761"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T13:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8659_00000523.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs40272-016-0172-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40272-016-0172-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40272-016-0172-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40272-016-0172-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40272-016-0172-6'


 

This table displays all metadata directly associated to this object as RDF triples.

160 TRIPLES      21 PREDICATES      57 URIs      26 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40272-016-0172-6 schema:about N3834b0b62d124c2f87648bfe5d9c862e
2 N4f7e0008489b42b4aae3d2a9e32807f0
3 N84be9778741d4f01b9dbd35e5b5bb608
4 Nddcd30e3710040c18a16d2742c0d2868
5 Nf723bd373b94498d88e158d90ef70e96
6 anzsrc-for:11
7 anzsrc-for:1117
8 schema:author N251ad1644e8a4ad2befda594a8281eab
9 schema:citation sg:pub.10.1038/eye.2011.233
10 sg:pub.10.1038/eye.2014.237
11 https://doi.org/10.1001/archophthalmol.2011.40
12 https://doi.org/10.1016/j.ajo.2010.07.022
13 https://doi.org/10.1016/j.ajo.2012.06.021
14 https://doi.org/10.1016/j.jpeds.2006.12.003
15 https://doi.org/10.1016/s0002-9394(14)78109-7
16 https://doi.org/10.1056/nejmc0708819
17 https://doi.org/10.1056/nejmoa1404710
18 https://doi.org/10.1111/bjd.12189
19 https://doi.org/10.1111/bjd.12217
20 https://doi.org/10.1111/bjd.12432
21 https://doi.org/10.1111/bjd.12804
22 https://doi.org/10.1111/bjd.14233
23 https://doi.org/10.1111/j.1365-2125.1985.tb02686.x
24 https://doi.org/10.1111/j.1440-1754.2012.02521.x
25 https://doi.org/10.1111/pde.12239
26 https://doi.org/10.1136/adc.2010.208884
27 https://doi.org/10.1136/archdischild-2014-306514
28 https://doi.org/10.1136/bjophthalmol-2011-300047
29 https://doi.org/10.1542/peds.2010-0029
30 https://doi.org/10.1542/peds.2012-1691
31 https://doi.org/10.4103/0974-2077.129975
32 schema:datePublished 2016-06
33 schema:datePublishedReg 2016-06-01
34 schema:description Oral propranolol is now established as the first-line treatment for infantile haemangiomas, and used in up to 20 % of all cases. Propranolol use in infants is most commonly instigated in a controlled environment to monitor for potential serious adverse events such as hypoglycaemia and hypotension. Two test doses are recommended, the first one of 300 μg/kg followed by 2-hourly monitoring. On the subsequent day, a further dose of 650 μg/kg is administered with the same monitoring. A dose of 2 mg/kg divided into three is started from the next day. Parents/carers need to be warned of common adverse effects, of which disturbed sleep is the commonest. Treatment is recommended for up to a year to avoid rebound growth and the need to restart the treatment.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree false
38 schema:isPartOf Nbb2cbe7e36bd49679417ce55c389a984
39 Nda86f33be5c3430e9ef7c4a1d069b3da
40 sg:journal.1020815
41 schema:name Infantile Periocular Haemangioma: Optimising the Therapeutic Response
42 schema:pagination 157-160
43 schema:productId N0522cf9135ab43b2870e203dc8181a9e
44 N16161eedfa724f83bf9b72d8c1990314
45 Nb8b8157a864e4e419b3b003115d94fa3
46 Nb90cd65f41ea4701a55fc2afccc7a7fd
47 Nc034439f1c71411a88a4993605b9c11a
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034087761
49 https://doi.org/10.1007/s40272-016-0172-6
50 schema:sdDatePublished 2019-04-10T13:20
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N2a1bd679121142b991c6c8afcc4f2a6e
53 schema:url http://link.springer.com/10.1007%2Fs40272-016-0172-6
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N0522cf9135ab43b2870e203dc8181a9e schema:name dimensions_id
58 schema:value pub.1034087761
59 rdf:type schema:PropertyValue
60 N16161eedfa724f83bf9b72d8c1990314 schema:name nlm_unique_id
61 schema:value 100883685
62 rdf:type schema:PropertyValue
63 N251ad1644e8a4ad2befda594a8281eab rdf:first sg:person.01366364604.16
64 rdf:rest rdf:nil
65 N2a1bd679121142b991c6c8afcc4f2a6e schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N3834b0b62d124c2f87648bfe5d9c862e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Infant
69 rdf:type schema:DefinedTerm
70 N4f7e0008489b42b4aae3d2a9e32807f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Humans
72 rdf:type schema:DefinedTerm
73 N84be9778741d4f01b9dbd35e5b5bb608 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Adrenergic beta-Antagonists
75 rdf:type schema:DefinedTerm
76 Nb8b8157a864e4e419b3b003115d94fa3 schema:name pubmed_id
77 schema:value 27043724
78 rdf:type schema:PropertyValue
79 Nb90cd65f41ea4701a55fc2afccc7a7fd schema:name readcube_id
80 schema:value a2627121343bcf6f9b41313f83a65230af365992e9069671d0f95ee37b115eff
81 rdf:type schema:PropertyValue
82 Nbb2cbe7e36bd49679417ce55c389a984 schema:issueNumber 3
83 rdf:type schema:PublicationIssue
84 Nc034439f1c71411a88a4993605b9c11a schema:name doi
85 schema:value 10.1007/s40272-016-0172-6
86 rdf:type schema:PropertyValue
87 Nda86f33be5c3430e9ef7c4a1d069b3da schema:volumeNumber 18
88 rdf:type schema:PublicationVolume
89 Nddcd30e3710040c18a16d2742c0d2868 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Propranolol
91 rdf:type schema:DefinedTerm
92 Nf723bd373b94498d88e158d90ef70e96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Hemangioma, Capillary
94 rdf:type schema:DefinedTerm
95 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
96 schema:name Medical and Health Sciences
97 rdf:type schema:DefinedTerm
98 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
99 schema:name Public Health and Health Services
100 rdf:type schema:DefinedTerm
101 sg:journal.1020815 schema:issn 1174-5878
102 1179-2019
103 schema:name Pediatric Drugs
104 rdf:type schema:Periodical
105 sg:person.01366364604.16 schema:affiliation https://www.grid.ac/institutes/grid.417375.3
106 schema:familyName Taylor
107 schema:givenName Robert H.
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366364604.16
109 rdf:type schema:Person
110 sg:pub.10.1038/eye.2011.233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025833378
111 https://doi.org/10.1038/eye.2011.233
112 rdf:type schema:CreativeWork
113 sg:pub.10.1038/eye.2014.237 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043249771
114 https://doi.org/10.1038/eye.2014.237
115 rdf:type schema:CreativeWork
116 https://doi.org/10.1001/archophthalmol.2011.40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041058827
117 rdf:type schema:CreativeWork
118 https://doi.org/10.1016/j.ajo.2010.07.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034890388
119 rdf:type schema:CreativeWork
120 https://doi.org/10.1016/j.ajo.2012.06.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031951898
121 rdf:type schema:CreativeWork
122 https://doi.org/10.1016/j.jpeds.2006.12.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046282100
123 rdf:type schema:CreativeWork
124 https://doi.org/10.1016/s0002-9394(14)78109-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026485403
125 rdf:type schema:CreativeWork
126 https://doi.org/10.1056/nejmc0708819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019302191
127 rdf:type schema:CreativeWork
128 https://doi.org/10.1056/nejmoa1404710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017117120
129 rdf:type schema:CreativeWork
130 https://doi.org/10.1111/bjd.12189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028491029
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1111/bjd.12217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016485182
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1111/bjd.12432 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035738030
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1111/bjd.12804 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003194294
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1111/bjd.14233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010054941
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1111/j.1365-2125.1985.tb02686.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041372361
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1111/j.1440-1754.2012.02521.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031512903
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1111/pde.12239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049929192
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1136/adc.2010.208884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002012463
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1136/archdischild-2014-306514 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012684038
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1136/bjophthalmol-2011-300047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000004025
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1542/peds.2010-0029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067828291
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1542/peds.2012-1691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027114703
155 rdf:type schema:CreativeWork
156 https://doi.org/10.4103/0974-2077.129975 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036766525
157 rdf:type schema:CreativeWork
158 https://www.grid.ac/institutes/grid.417375.3 schema:alternateName York Hospital
159 schema:name Eye Department, York Hospital, Wigginton Road, YO31 8HE, York, England
160 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...